Cover Image
市場調查報告書

電腦支援檢測 (CAD) 市場分析:各用途 (乳癌,肺癌,大腸癌,前列腺癌,肝癌,骨癌,神經/肌肉骨骼/心血管) 、胸部CAD顯像模式,顯像模式及市場區隔預測

Computer Aided Detection (CAD) Market Analysis By Application (Breast, Lung, Colon/Rectal, Prostate, Liver, Bone, Neurological/Musculoskeletal/Cardiovascular Cancer), By Breast CAD Imaging Modalities, By Imaging Modalities And Segment Forecasts To 2022

出版商 Grand View Research, Inc. 商品編碼 370404
出版日期 內容資訊 英文 66 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
電腦支援檢測 (CAD) 市場分析:各用途 (乳癌,肺癌,大腸癌,前列腺癌,肝癌,骨癌,神經/肌肉骨骼/心血管) 、胸部CAD顯像模式,顯像模式及市場區隔預測 Computer Aided Detection (CAD) Market Analysis By Application (Breast, Lung, Colon/Rectal, Prostate, Liver, Bone, Neurological/Musculoskeletal/Cardiovascular Cancer), By Breast CAD Imaging Modalities, By Imaging Modalities And Segment Forecasts To 2022
出版日期: 2016年08月07日 內容資訊: 英文 66 Pages
簡介

本報告提供全球電腦支援檢測 (CAD) 市場相關調查,彙整市場各用途,胸部CAD顯像模式,顯像模式別趨勢,今後預測,及加入此市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素
    • 阻礙市場的要素
  • 被優先的主要的機會
  • 產業分析:波特五力分析
  • PESTEL分析

第4章 各用途市場

  • 各用途市場佔有率
  • 乳癌
  • 肺癌
  • 大腸癌
  • 前列腺癌
  • 肝癌
  • 骨癌
  • 神經/肌肉骨骼/心血管適應

第5章 乳癌顯像模式預測

  • 乳癌顯像模式別佔有率
  • 乳房X光攝影
  • MRI
  • 超音波
  • 斷層攝影
  • 核子醫學攝影
  • 其他

第6章 顯像模式預測

  • 顯像模式別佔有率
  • X光掃描
  • MRI
  • CT
  • 超音波
  • 核醫學影像
  • 其他

第7章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第8章 競爭環境

  • EDDA technology, Inc.
  • FUJIFILM Medical株式會社
  • 株式會社 日立先端科技
  • Hologic Inc.
  • iCAD, Inc.
  • Vucomp
  • McKesson Corporation
  • Philips healthcare
  • Siemens Healthcare
  • 東芝MedicalSystems株式會社

圖表

目錄
Product Code: 978-1-68038-994-4

Global computer aided detection market is expected to reach USD 1.9 billion by 2022, according to a new report by Grand View Research Inc. CAD software tools have been introduced to support radiologists to cope with the growing number of images requiring interpretation. Increasing incidence rate of breast, prostate and lung cancer, rising technological advancements, and increasing use of CAD with other imaging modalities such as ultrasound and magnetic resonance imaging are expected to serve this industry as high-impact rendering drivers.

In the U.S., prostate cancer is one of the most common cancers amongst men and has increased the demand for multi-parametric Magnetic Resonance Imaging (MP-MRI) CADx systems for diagnosis and detection of prostate cancer.

In screening mammography, the traditional concept of double reading by the second clinician is expected to be replaced by CAD, of breast cancer completely. This is due to the additional reimbursement generated by computer-aided detection unlike the double readings that demand more of radiologists' time without any reimbursement for the second read.

Wide research has been undertaken to come up with new findings establishing the relation of cancer with anatomy. For instance, Johns Hopkins researchers established the presence of dense clumps of bacteria in ascending colon to cancer.

CAD is most widely used for breast cancer imaging due to a higher incidence of cancer in women with morbidity of 14 million new cases and 8.2 deaths according to the WHO 2012. With the increasing demand for imaging and the growing rate of chronic diseases, the demand for imaging technologies is expected to increase. Computer aided detection is now used with other imaging modalities such as ultrasound, nuclear imaging, magnetic resonance imaging, etc.

In 2014, mammography dominated the industry as the prevalence of cancer is high and is the leading cause of morbidity and mortality. According to the World Cancer Research Fund International 2012, North America and Oceania have the highest incidence rate of breast cancer and Asia and Africa has the lowest.

Digital imaging technique advancements are the other contributing factors for market growth as it has increased ease-of-integration of CAD solutions with imaging equipment and has also improved the efficiency of computer aided detection solutions.

Further key findings from the study suggest:

In 2014, mammography dominated the market due to the fact that it has high potential for breast cancer imaging and was one of the first segments in which companies developed CAD software and till date most of it is working on this indication.

According to the WHO data 2012, there were 14 million new cases of breast cancer. The increasing awareness has led increase in regular cancer check-ups as a preventive step.

The demand for CAD has grown in chest imaging such as low-dose lung cancer screening due to Multidetector Computed Tomography (MDCT) indications. Furthermore, CAD has been brought in use for established areas of chest CT such as diagnosis of interstitial lung disease and acute Pulmonary Embolism (PE).

CAD is also used with other imaging modalities such as x-ray, computed tomography, and ultrasound. Out of these, the use of CAD for x-ray imaging is the highest as it is the basic imaging and due to the recent advances overcoming its limitations of soft tissue imaging.

North America was the most revenue generating region of the market. The market contributed more than 40% of the revenue in 2014. Constant efforts to fuel the market with newer technologies and the use of computer aided detection for integrative diagnosis apart from image analysis are expected to drive regional market growth over the forecast period.

Asia Pacific and Europe are expected to spearhead future market growth due to the availability of cost-effective technologies and rise in medical tourism. UK cancer patients mostly treat themselves in Eastern Europe, Germany, France, and Spain as these nations specialize in cancer treatments, and as flights to these destinations are relatively cheaper and consume lesser time.

Key market players are EDDA Technology, Inc., FUJIFILM Medical Systems, Hitachi High Technologies Corporation, Hologic Inc., iCAD, Inc., Vucomp, McKesson Corporation, Philips Healthcare, Siemens Healthcare, and Toshiba Medical Systems Corporation.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Computer Aided Detection (CAD) Market - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Computer Aided Detection (CAD) Industry Outlook

  • 3.1. Computer Aided Detection (CAD) Market Segmentation
  • 3.2. Computer Aided Detection (CAD) Market Size And Growth Prospects
  • 3.3. Computer Aided Detection (CAD) Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Computer Aided Detection (CAD) Market PESTEL Analysis, 2014

Chapter 4. Computer Aided Detection (CAD) Application Outlook

  • 4.1. Computer Aided Detection (CAD) Share by Application, 2014 & 2022
  • 4.2. Breast Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.3. Lung Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.4. Colon/Rectal Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.5. Prostate Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.6. Liver Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.7. Bone Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 4.8. Neurological/ Musculoskeletal/ Cardiovascular Indications Market Estimates And Forecasts, 2012 - 2022 (USD Million)

Chapter 5. Computer Aided Detection (CAD) Brest Cancer Imaging Modalities Outlook

  • 5.1. Computer Aided Detection (CAD) Share By Breast Cancer Imaging Modalities, 2014 & 2022
  • 5.2. Mammography Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.3. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.4. Ultrasound Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.5. Tomosynthesis Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.6. Nuclear Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 5.7. Others Market Estimates And Forecasts, 2012 - 2022 (USD Million)

Chapter 6. Computer Aided Detection (CAD) Imaging Modalities Outlook

  • 6.1. Computer Aided Detection (CAD) Share By Imaging Modalities, 2014 & 2022
  • 6.2. X-Ray ImagingMarket Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.3. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.4. Computed Tomography Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.5. Ultrasound Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.6. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.7. Nuclear Medicine Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 6.8. OthersMarket Estimates And Forecasts, 2012 - 2022 (USD Million)

Chapter 7. Computer Aided Detection (CAD) Regional Outlook

  • 7.1. North America
    • 7.1.1. North America Computer Aided Detection (CAD) Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million)
    • 7.1.2. North America Computer Aided Detection (CAD) market Estimates And Forecasts, By Brest Cancer Imaging Modalities, 2012 - 2022 (USD Million)
    • 7.1.3. North America Computer Aided Detection (CAD) market Estimates And Forecasts, By End-use, 2012 - 2022 (USD Million)
  • 7.2. Europe
    • 7.2.1. Europe Computer Aided Detection (CAD) Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million)
    • 7.2.2. Europe Computer Aided Detection (CAD) Market Estimates And Forecasts, By Brest Cancer Imaging Modalities, 2012 - 2022 (USD Million)
    • 7.2.3. Europe Computer Aided Detection (CAD) Market Estimates And Forecasts, By Imaging Modalities, 2012 - 2022 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific Computer Aided Detection (CAD) Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million)
    • 7.3.2. Asia Pacific Computer Aided Detection (CAD) Market Estimates And Forecasts, By Brest Cancer Imaging Modalities, 2012 - 2022 (USD Million)
    • 7.3.3. Asia Pacific Computer Aided Detection (CAD) Market Estimates And Forecasts, By Imaging Modalities, 2012 - 2022 (USD Million)
  • 7.4. RoW
    • 7.4.1. Row Computer Aided Detection (CAD) Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million)
    • 7.4.2. Row Computer Aided Detection (CAD) Market Estimates And Forecasts, By Brest Cancer Imaging Modalities, 2012 - 2022 (USD Million)
    • 7.4.3. Row Computer Aided Detection (CAD) Market Estimates And Forecasts, By Imaging Modalities, 2012 - 2022 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. EDDA technology, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Technology Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. FUJIFILM Medical Systems
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Technology Benchmarking
    • 8.2.4. Strategic Initiatives
  • 8.3. Hitachi High Technologies Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Technology Benchmarking
    • 8.3.4. Strategic Initiatives
  • 8.4. Hologic Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Technology Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. iCAD, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Technology Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. Vucomp
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Technology Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. McKesson Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Technology Benchmarking
    • 8.7.4. Strategic Initiatives
  • 8.8. Philips healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Technology Benchmarking
    • 8.8.4. Strategic Initiatives
  • 8.9. Siemens Healthcare
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Technology Benchmarking
    • 8.9.4. Strategic Initiatives
  • 8.10. Toshiba Medical Systems Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Technology Benchmarking
    • 8.10.4. Strategic Initiatives

List of Tables

  • 1. Computer Aided Detection (CAD) Market- Industry Summary & Key Buying Criteria, 2012 - 2022
  • 2. Computer Aided Detection (CAD) Market, by Application, 2012 - 2022 (USD million)
  • 3. Computer Aided Detection (CAD) Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 4. Computer Aided Detection (CAD) Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 5. Computer Aided Detection (CAD), by Region, 2012 - 2022 (USD million)
  • 6. Computer Aided Detection (CAD) Market - Key Market Drivers Analysis
  • 7. Computer Aided Detection (CAD) Market - Key Market Restraints Analysis
  • 8. North America Market, by Application, 2012 - 2022 (USD million)
  • 9. North America Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 10. North America Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 11. Europe Market, by Application, 2012 - 2022 (USD million)
  • 12. Europe Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 13. Europe Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 14. Asia Pacific Market, by Application, 2012 - 2022 (USD million)
  • 15. Asia Pacific Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 16. Asia Pacific Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 17. RoW Market, by Application, 2012 - 2022 (USD million)
  • 18. RoW Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 19. RoW Market, by Imaging Modalities, 2012 - 2022 (USD million)

List of Figures

  • 1. Computer Aided Detection (CAD) Market Segmentation
  • 2. Global Computer Aided Detection (CAD) Market Revenue, 2012 - 2022
  • 3. Computer Aided Detection (CAD) Market Dynamics
  • 4. Key Opportunities Prioritized
  • 5. Computer Aided Detection (CAD) Market Analysis - Porter's
  • 6. Computer Aided Detection (CAD) Market Analysis - PESTEL Analysis
  • 7. Global Computer Aided Detection (CAD) Market, By Application, 2012 - 2022 (USD million)
  • 8. Breast Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 9. Lung Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 10. Colon/Rectal Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 11. Prostate Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 12. Liver Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 13. Bone Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 14. Neurological/ Musculoskeletal/ Cardiovascular Indications Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 15. Global Computer Aided Detection (CAD) Market, By Breast Cancer Imaging Modalities , 2012 - 2022 (USD million)
  • 16. Mammography Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 17. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 18. Ultrasound Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 19. Tomosynthesis Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 20. Nuclear Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 21. Others Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 22. Global Computer Aided Detection (CAD) Market, By Imaging Modalities, 2012 - 2022 (USD million)
  • 23. X-Ray Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 24. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 25. Computed Tomography Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 26. Ultrasound Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 27. Magnetic Resonance Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 28. Nuclear Medicine Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 29. Others Market Estimates And Forecasts, 2012 - 2022 (USD Million)
  • 30. Global Computer Aided Detection (CAD) Market, By Region 2012 to 2022 (USD million)
  • 31. North America Market, by Application, 2012 - 2022 (USD million)
  • 32. North America Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 33. North America Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 34. Europe Market, by Application, 2012 - 2022 (USD million)
  • 35. Europe Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 36. Europe Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 37. Asia Pacific Market, by Application, 2012 - 2022 (USD million)
  • 38. Asia Pacific Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 39. Asia Pacific Market, by Imaging Modalities, 2012 - 2022 (USD million)
  • 40. RoW Market, by Application, 2012 - 2022 (USD million)
  • 41. RoW Market, by Breast Cancer Imaging Modalities, 2012 - 2022 (USD million)
  • 42. RoW Market, by Imaging Modalities, 2012 - 2022 (USD million)
Back to Top